NeoStem (Nasdaq: NBS)
Investing - Small-Cap Market Intelligence • 4m 41s
Host Thomas Pfister, CFA interviews Robin Smith, M.D., CEO of NeoStem (Nasdaq: NBS), a biopharmaceutical company pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function,
Up Next in Investing - Small-Cap Market Intelligence
-
Giggles n' Hugs (OTCQB: GIGL)
Giggles n' Hugs (OTCQB: GIGL) is the first and only restaurant that brings together high-end, organic food with play elements and entertainment for children. GIGL offers an upscale, family-friendly atmosphere with a play area filled with climbers, life size pirate ships and castles dedicated to c...
-
Green Spirit Industries Inc. (OTC: GSRX)
Green Spirit Industries Inc. (OTC: GSRX), together with its wholly-owned subsidiary, Project 1493, LLC, is in the business of acquiring, developing and operating medical marijuana dispensaries. Project 1493 is in the process of acquiring five (5) pre-approved medical marijuana dispensaries locate...
-
Mission Zero
